Navigation Links
Nitto Denko Avecia Inc. Strengthens its Commitment to the Small Molecule and Radiochemistry Industries by Hiring Hamilton J. Lenox as Director of Business Development
Date:12/19/2013

(PRWEB) December 19, 2013

Nitto Denko Avecia Inc., an industry leader in process development and commercial manufacturing, is proud to announce that it has hired Hamilton J. Lenox as its new Director of Business Development. Hamilton initially will focus on the small molecule and radiochemistry units of Avecia, and also will be handling marketing for the organization. Hamilton brings both a strong technical background and significant business development expertise to Avecia, including familiarity both with clients and the outsourcing markets in North America, Europe and Asia.

The hiring of Hamilton, who is well known in the small molecule industry, demonstrates Avecia’s continuing commitment to their small molecule and radiochemistry customers. Early in 2013 Avecia acquired the contract manufacturing business of Girindus America Inc., adding small molecule API manufacturing and radiochemistry capabilities while expanding Avecia’s best in class oligonucleotide offerings.

Hamilton says he is excited to join Nitto Denko Avecia, Inc., a company well-known for their excellent reputation and strong leadership. “I look forward to expanding our client base in my new role, and know our existing and future clients will continue to be impressed with Avecia’s commitment to quality in everything we do,” says Hamilton. He notes that the acquisition of Girindus America’s contract manufacturing business not only keeps Avecia positioned as the leader of the oligonucleotide manufacturing market, but also significantly expands their capabilities.

Additionally, small molecule services have complemented Avecia’s oligonucleotide business due to both units’ expertise in difficult conjugation chemistry, and Avecia now can produce any necessary small molecule linkers / conjugates in-house. The expertise of Avecia’s oligo team also has benefited the small molecule unit by providing additional expertise that clearly positions Avecia as a leader in developing and manufacturing small molecule nucleotide derivatives and analogs. There also is a strong synergy between the oligo and radiochemistry units, as this combination marks Avecia as one of the only radiochemistry facilities in the world with significant expertise in oligo synthesis.

About Nitto Denko Avecia, Inc.:
Nitto Denko Avecia, Inc., is a drug development and manufacturing services company with headquarters in Milford, MA, and is a part of Nitto Denko Corporation, Japan’s leading diversified materials manufacturer. Avecia is a recognized leader in the oligonucleotide therapeutic market, and with the acquisition of Girindus America’s contract manufacturing business in 2013 has added radiochemistry and small molecule API development and manufacturing to its portfolio of services. Avecia’s oligonucleotide facilities (in Milford, MA, and Cincinnati, OH) support DNA and RNA-based therapeutics throughout their lifecycle, and include such services as process and analytical development and pre-clinical production through large scale cGMP commercial manufacturing. To see what Avecia can do for your business, visit http://www.avecia.com.

Read the full story at http://www.prweb.com/releases/2013/12/prweb11430949.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. NITTO DENKO Avecia Inc. Introduces Dedicated Pre-Clinical Oligonucleotide Service, OliGrow
2. Intrexon Strengthens Leadership in Companys Rapidly Growing Health Sector
3. Gallus Strengthens Biologics CMO Business with Acquisition of Laureate
4. inVentiv Health Clinical Expands and Strengthens Executive Team with Three Strategic Appointments
5. SentoClone International AB Significantly Strengthens its Global Patent Portfolio Covering its Clinical Stage Sentinel Node-derived CD4 T-cell Cancer Therapy
6. BellBrook Labs Strengthens Ties with Cambio for Distribution of Transcreener HTS Assays in the UK
7. Cytos Biotechnology Strengthens Management Team
8. Delta Point Strengthens Management and Expands Consultancy Services with Addition of Former AstraZeneca Executive Michael Hickey
9. Molecular Detection Inc. Further Strengthens Patent Portfolio Broadly Covering Detection of Antibiotic-Resistant Bacteria
10. AMRI Strengthens Business Development and Marketing Groups
11. Hospira Names Zena G. Kaufman Senior Vice President of Quality; Strengthens Quality and Compliance Capabilities With Addition of Top Industry Talent
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/12/2016)... SAN FRANCISCO , February 12, 2016 /PRNewswire/ ... Precision Medicine Efforts by Enabling Scientific Understanding of ... Disorders and Rare Diseases --> ... for genomic diagnostics in South Asia and a leading ... it would contribute $10 million to the GenomeAsia ...
(Date:2/11/2016)... Biosciences, Inc. (NASDAQ: NBIX ) today announced its financial results ... --> --> For the fourth quarter ... or $0.34 loss per share, compared to a net loss of ... in 2014. For the year ended December 31, 2015, the Company ... share, as compared to a net loss of $60.5 million, or ...
(Date:2/11/2016)... Germany and GERMANTOWN, Maryland ... QGEN ; Frankfurt Prime Standard: QIA) today announced the ... Panels for gene expression profiling, expanding QIAGEN,s portfolio of ... panels enable researchers to select from over 20,000 human ... discover interactions between genes, cellular phenotypes and disease processes. ...
(Date:2/11/2016)... , Feb. 11, 2016  Spectra BioPharma Selling ... (CSO) that provides biopharma companies the experience, expertise, ... and deploy outsourced sales teams. Created in concert ... addresses both the strategic and tactical needs of ... sales solutions through both personal and non-personal promotion. ...
Breaking Biology Technology:
(Date:2/2/2016)... 2016   Parabon NanoLabs (Parabon) announced ... Research Office and the Defense Forensics and Biometrics ... the company,s Snapshot Kinship Inference software ... generally, defense-related DNA forensics.  Although Snapshot is best ... and ancestry from DNA evidence), it also has ...
(Date:2/1/2016)... -- Rising sales of consumer electronics coupled ... gesture control market size through ... electronics coupled with new technological advancements to drive global ... through 2020   --> Rising ... to drive global touchfree intuitive gesture control market ...
(Date:2/1/2016)... MELBOURNE, Fla. , Feb. 1, 2016  Wocket® smart wallet ( ... actor and television personality, Joey Fatone . Las ... and greet fans. --> Las Vegas , ... --> The new video ad was filmed at the ... Joey appeared at the Wocket booth to meet and greet fans. ...
Breaking Biology News(10 mins):